{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:07:21Z","timestamp":1784012841886,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00520-026-10937-y","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:22:10Z","timestamp":1782386530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization and outcomes of severe complications after autologous hematopoietic stem-cell transplantation: a retrospective multicenter study"],"prefix":"10.1007","volume":"34","author":[{"given":"Corentin","family":"Le Cacheux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Le Thuaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Orieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Courtot-Melciolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Chanut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Quelven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-8082","authenticated-orcid":false,"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"10937_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa2204925","volume":"387","author":"PG Richardson","year":"2022","unstructured":"Richardson PG, Jacobus SJ, Weller EA et al (2022) Triplet therapy, transplantation, and maintenance until progression in myeloma. N Engl J Med 387:132\u2013147. https:\/\/doi.org\/10.1056\/NEJMoa2204925","journal-title":"N Engl J Med"},{"key":"10937_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bbmt.2015.02.022","volume":"21","author":"M-A Perales","year":"2015","unstructured":"Perales M-A, Ceberio I, Armand P et al (2015) Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21:971\u2013983. https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.022","journal-title":"Biol Blood Marrow Transplant"},{"key":"10937_CR3","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cncr.31374","volume":"124","author":"SM Smith","year":"2018","unstructured":"Smith SM, Godfrey J, Ahn KW et al (2018) Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Cancer 124:2541\u20132551. https:\/\/doi.org\/10.1002\/cncr.31374","journal-title":"Cancer"},{"key":"10937_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1182\/bloodadvances.2019001355","volume":"4","author":"RW Merryman","year":"2020","unstructured":"Merryman RW, Edwin N, Redd R et al (2020) Rituximab\/bendamustine and rituximab\/cytarabine induction therapy for transplant-eligible mantle cell lymphoma. Blood Adv 4:858\u2013867. https:\/\/doi.org\/10.1182\/bloodadvances.2019001355","journal-title":"Blood Adv"},{"key":"10937_CR5","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/bloodadvances.2024015415","volume":"9","author":"L Bento","year":"2025","unstructured":"Bento L, Guti\u00e9rrez A, Mart\u00ednez C et al (2025) Autologous stem cell transplantation for relapsed\/refractory large B-cell lymphoma: a multicenter GETH-TC\/GELTAMO study. Blood Adv 9:3281\u20133292. https:\/\/doi.org\/10.1182\/bloodadvances.2024015415","journal-title":"Blood Adv"},{"key":"10937_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1378\/chest.10-2889","volume":"141","author":"B Afessa","year":"2012","unstructured":"Afessa B, Abdulai RM, Kremers WK et al (2012) Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest 141:442\u2013450. https:\/\/doi.org\/10.1378\/chest.10-2889","journal-title":"Chest"},{"key":"10937_CR7","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","volume":"26","author":"N Blijlevens","year":"2008","unstructured":"Blijlevens N, Schwenkglenks M, Bacon P et al (2008) Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 26:1519\u20131525. https:\/\/doi.org\/10.1200\/JCO.2007.13.6028","journal-title":"J Clin Oncol"},{"key":"10937_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1365-2141.2003.04767.x","volume":"124","author":"KS Peggs","year":"2004","unstructured":"Peggs KS, Mackinnon S (2004) Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol 124:407\u2013420. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04767.x","journal-title":"Br J Haematol"},{"key":"10937_CR9","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.bbmt.2016.06.007","volume":"22","author":"SA Graf","year":"2016","unstructured":"Graf SA, Vaughn JE, Chauncey TR et al (2016) Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 22:1582\u20131587. https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.007","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10937_CR10","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.bbmt.2008.06.019","volume":"14","author":"L Labont\u00e9","year":"2008","unstructured":"Labont\u00e9 L, Iqbal T, Zaidi MA et al (2008) Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 14:1039\u20131044. https:\/\/doi.org\/10.1016\/j.bbmt.2008.06.019","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10937_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","volume":"45","author":"M Darmon","year":"2019","unstructured":"Darmon M, Bourmaud A, Georges Q et al (2019) Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45:977\u2013987. https:\/\/doi.org\/10.1007\/s00134-019-05653-7","journal-title":"Intensive Care Med"},{"key":"10937_CR12","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, P\u00e8ne F et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study. J Clin Oncol 31:2810\u20132818. https:\/\/doi.org\/10.1200\/JCO.2012.47.2365","journal-title":"J Clin Oncol"},{"key":"10937_CR13","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","volume":"47","author":"BL Ferreyro","year":"2021","unstructured":"Ferreyro BL, Scales DC, Wunsch H et al (2021) Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 47:1104\u20131114. https:\/\/doi.org\/10.1007\/s00134-021-06502-2","journal-title":"Intensive Care Med"},{"key":"10937_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1164\/ajrccm.158.3.9711076","volume":"158","author":"KJ Price","year":"1998","unstructured":"Price KJ, Thall PF, Kish SK et al (1998) Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 158:876\u2013884. https:\/\/doi.org\/10.1164\/ajrccm.158.3.9711076","journal-title":"Am J Respir Crit Care Med"},{"key":"10937_CR15","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3109\/10428194.2015.1034700","volume":"56","author":"L Kerhuel","year":"2015","unstructured":"Kerhuel L, Amorim S, Azoulay E et al (2015) Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma. Leuk Lymphoma 56:3090\u20133095. https:\/\/doi.org\/10.3109\/10428194.2015.1034700","journal-title":"Leuk Lymphoma"},{"key":"10937_CR16","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.bbmt.2015.07.026","volume":"21","author":"P Jenkins","year":"2015","unstructured":"Jenkins P, Johnston LJ, Pickham D et al (2015) Intensive care utilization for hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 21:2023\u20132027. https:\/\/doi.org\/10.1016\/j.bbmt.2015.07.026","journal-title":"Biol Blood Marrow Transplant"},{"key":"10937_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154077","volume":"71","author":"AP Nassar","year":"2022","unstructured":"Nassar AP, Archanjo LVF, Ranzani OT et al (2022) Characteristics and outcomes of autologous hematopoietic stem cell transplant recipients admitted to intensive care units: a multicenter study. J Crit Care 71:154077. https:\/\/doi.org\/10.1016\/j.jcrc.2022.154077","journal-title":"J Crit Care"},{"key":"10937_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00277-022-05028-x","volume":"102","author":"J Garcia Borrega","year":"2023","unstructured":"Garcia Borrega J, B\u00f6ll B, Kochanek M et al (2023) Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis. Ann Hematol 102:191\u2013197. https:\/\/doi.org\/10.1007\/s00277-022-05028-x","journal-title":"Ann Hematol"},{"key":"10937_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"10937_CR20","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963. https:\/\/doi.org\/10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"key":"10937_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707\u2013710. https:\/\/doi.org\/10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"issue":"6","key":"10937_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649","journal-title":"Am J Clin Oncol"},{"key":"10937_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/j.1532-5415.2011.03597.x","volume":"59","author":"SA Sternberg","year":"2011","unstructured":"Sternberg SA, Wershof Schwartz A, Karunananthan S et al (2011) The identification of frailty: a systematic literature review. J Am Geriatr Soc 59:2129\u20132138. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03597.x","journal-title":"J Am Geriatr Soc"},{"key":"10937_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5306\/wjco.v7.i1.98","volume":"7","author":"UD Bayraktar","year":"2016","unstructured":"Bayraktar UD, Nates JL (2016) Intensive care outcomes in adult hematopoietic stem cell transplantation patients. World J Clin Oncol 7:98\u2013105. https:\/\/doi.org\/10.5306\/wjco.v7.i1.98","journal-title":"World J Clin Oncol"},{"key":"10937_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ccc.2009.09.001","volume":"26","author":"B Afessa","year":"2010","unstructured":"Afessa B, Azoulay E (2010) Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 26:133\u2013150. https:\/\/doi.org\/10.1016\/j.ccc.2009.09.001","journal-title":"Crit Care Clin"},{"key":"10937_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/bmt.2008.336","volume":"43","author":"MA Trinkaus","year":"2009","unstructured":"Trinkaus MA, Lapinsky SE, Crump M et al (2009) Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant 43:411\u2013415. https:\/\/doi.org\/10.1038\/bmt.2008.336","journal-title":"Bone Marrow Transplant"},{"key":"10937_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bbmt.2005.10.020","volume":"12","author":"AK Kew","year":"2006","unstructured":"Kew AK, Couban S, Patrick W et al (2006) Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 12:301\u2013305. https:\/\/doi.org\/10.1016\/j.bbmt.2005.10.020","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10937_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2141.2006.06440.x","volume":"136","author":"Z Lim","year":"2007","unstructured":"Lim Z, Pagliuca A, Simpson S et al (2007) Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. Br J Haematol 136:448\u2013450. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06440.x","journal-title":"Br J Haematol"},{"key":"10937_CR29","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1378\/chest.126.5.1604","volume":"126","author":"AO Soubani","year":"2004","unstructured":"Soubani AO, Kseibi E, Bander JJ et al (2004) Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 126:1604\u20131611. https:\/\/doi.org\/10.1378\/chest.126.5.1604","journal-title":"Chest"},{"key":"10937_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf134","author":"A-S Brunel","year":"2025","unstructured":"Brunel A-S, Seydoux C, Schmidt S et al (2025) Epidemiology, risk factors and outcome of neutropenic enterocolitis in onco-hematological patients according to chemotherapy regimen. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaf134","journal-title":"Clin Infect Dis"},{"key":"10937_CR31","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41409-024-02398-w","volume":"59","author":"CJ Stathis","year":"2024","unstructured":"Stathis CJ, Zhu H, Carlin K et al (2024) A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant. Bone Marrow Transplant 59:1683\u20131693. https:\/\/doi.org\/10.1038\/s41409-024-02398-w","journal-title":"Bone Marrow Transplant"},{"key":"10937_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jinf.2019.05.001","volume":"79","author":"M Balsat","year":"2019","unstructured":"Balsat M, Pillet S, Tavernier E et al (2019) Human herpesvirus 6 infection after autologous stem cell transplantation: a multicenter prospective study in adult patients. J Infect 79:36\u201342. https:\/\/doi.org\/10.1016\/j.jinf.2019.05.001","journal-title":"J Infect"},{"key":"10937_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jcrc.2020.10.008","volume":"61","author":"Y Hourmant","year":"2021","unstructured":"Hourmant Y, Mailloux A, Valade S et al (2021) Impact of early ICU admission on outcome of critically ill and critically ill cancer patients: a systematic review and meta-analysis. J Crit Care 61:82\u201388. https:\/\/doi.org\/10.1016\/j.jcrc.2020.10.008","journal-title":"J Crit Care"},{"key":"10937_CR34","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1182\/blood.2022015789","volume":"139","author":"J Westin","year":"2022","unstructured":"Westin J, Sehn LH (2022) CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift? Blood 139:2737\u20132746. https:\/\/doi.org\/10.1182\/blood.2022015789","journal-title":"Blood"},{"key":"10937_CR35","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3324\/haematol.2023.283058","volume":"109","author":"M Engelhardt","year":"2024","unstructured":"Engelhardt M, Kort\u00fcm KM, Goldschmidt H, Merz M (2024) Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible. Haematologica 109:2420\u20132435. https:\/\/doi.org\/10.3324\/haematol.2023.283058","journal-title":"Haematologica"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10937-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:45:31Z","timestamp":1784011531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10937-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10937"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10937-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the French Intensive Care Society (CE SRLF 23\u2013068) on September 11, 2023. In accordance with French law on retrospective studies of anonymized healthcare data, informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EC has received lecturer and conference-speaker fees, as well as reimbursements of travel and accommodation expenses related to attending scientific meetings, from Gilead. LZ has received lecturer and conference-speaker fees from Sanofi and MSD. The other authors have no conflict of interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"690"}}